Wikidata entity: Q304088
C₁₉H₁₅NO₆ (P274)
Quantities
| P4250 | defined daily dose | 5 |
| P2067 | mass | 353.089937 |
| P233 | canonical SMILES | String | CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O | ??? |
| P373 | Commons category | String | Acenocoumarol | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q57055 (paracetamol) | paracetamol |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q307088 (abciximab) | abciximab |
| P769 | significant drug interaction | ... | Q238512 (fluorouracil) | fluorouracil |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q407241 (phenobarbital) | phenobarbital |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q411478 (fluconazole) | fluconazole |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q412178 (tamoxifen) | tamoxifen |
| P769 | significant drug interaction | ... | Q412236 (voriconazole) | voriconazole |
| P769 | significant drug interaction | ... | Q413370 ((RS)-tegafur) | (RS)-tegafur |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q414462 (apixaban) | apixaban |
| P769 | significant drug interaction | ... | Q415159 (rosuvastatin) | rosuvastatin |
| P769 | significant drug interaction | ... | Q415843 (sulfamethoxazole) | sulfamethoxazole |
| P769 | significant drug interaction | ... | Q416132 (betamethasone) | betamethasone |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q420207 (capecitabine) | capecitabine |
| P769 | significant drug interaction | ... | Q420262 (rivaroxaban) | rivaroxaban |
| P769 | significant drug interaction | ... | Q420542 (ticagrelor) | ticagrelor |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q416485 (Streptokinase) | Streptokinase |
| P769 | significant drug interaction | ... | Q417222 (methylprednisolone) | methylprednisolone |
| P769 | significant drug interaction | ... | Q419724 (fenofibrate) | fenofibrate |
| P769 | significant drug interaction | ... | Q422252 (dexamethasone) | dexamethasone |
| P769 | significant drug interaction | ... | Q424972 (prednisone) | prednisone |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q577387 (bezafibrate) | bezafibrate |
| P769 | significant drug interaction | ... | Q898407 (venlafaxine) | venlafaxine |
| P769 | significant drug interaction | ... | Q1644947 (tenecteplase) | tenecteplase |
| P769 | significant drug interaction | ... | Q1851701 (dalteparin) | dalteparin |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1074056 (triamcinolone) | triamcinolone |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q3563148 (vortioxetine) | vortioxetine |
| P769 | significant drug interaction | ... | Q5984881 (ibrutinib) | ibrutinib |
| P769 | significant drug interaction | ... | Q11426176 (prednisolone) | prednisolone |
| P769 | significant drug interaction | ... | Q20817252 (tinzaparin) | tinzaparin |
| P769 | significant drug interaction | ... | Q45769835 (alteplase) | alteplase |
| P769 | significant drug interaction | ... | Q47495791 (levofloxacin hemihydrate) | levofloxacin hemihydrate |
| P769 | significant drug interaction | ... | Q75163056 (rac-miconazole) | rac-miconazole |
| P769 | significant drug interaction | ... | Q105969996 (enoxaparin) | enoxaparin |
| P769 | significant drug interaction | ... | Q110969665 (urokinase) | urokinase |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q215118 (anticoagulant) | anticoagulant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | acenocoumarol | ??? |
| P267 | ATC code | B01AA07 |
| P231 | CAS Registry Number | 152-72-7 |
| P683 | ChEBI ID | 53766 |
| P592 | ChEMBL ID | CHEMBL397420 |
| P661 | ChemSpider ID | 10443441 |
| P715 | DrugBank ID | DB01418 |
| P11198 | DrugCentral ID | 48 |
| P8494 | DSSTOX compound identifier | DTXCID802541 |
| P3117 | DSSTox substance ID | DTXSID2022541 |
| P232 | EC number | 205-807-3 |
| P2566 | ECHA Substance Infocard ID | 100.005.281 |
| P646 | Freebase ID | /m/0fmd59 |
| P595 | Guide to Pharmacology Ligand ID | 9015 |
| P2062 | HSDB ID | 3201 |
| P2057 | Human Metabolome Database ID | HMDB0015487 |
| P234 | InChI | InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3 |
| P235 | InChIKey | VABCILAOYCMVPS-UHFFFAOYSA-N |
| P665 | KEGG ID | D07064 |
| P486 | MeSH descriptor ID | D000074 |
| P672 | MeSH tree code | D03.383.663.283.446.520.079 |
| P672 | MeSH tree code | D03.633.100.150.446.520.079 |
| P6366 | Microsoft Academic ID (discontinued) | 2781344064 |
| P2840 | NSC number | 760052 |
| P10283 | OpenAlex ID | C2781344064 |
| P11199 | Probes And Drugs ID | PD009504 |
| P662 | PubChem CID | 54676537 |
| P1579 | Reaxys registry number | 1269370 |
| P3345 | RxNorm CUI | 154 |
| P2877 | SureChEMBL ID | 33543 |
| P11089 | UniChem compound ID | 145715 |
| P652 | UNII | I6WP63U32H |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 503 |
Why not click here or view trends?
log id: 2973898